跳至主要内容
临床试验/EUCTR2012-005350-39-NL
EUCTR2012-005350-39-NL进行中(未招募)不适用

Effects Of extra-fine particle HFA-becLomethasone (HFA-QVAR) Versus course particle treatment In smokers and ex-smokers with Asthma - Effects of QVAR in smokers and ex-smokers with asthma

niversity Medical Centre Groningen0 个研究点开始时间: 2013年4月22日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Males and females with a doctor’s diagnosis of asthma
  • Age between 18 and 65 years
  • Current- and ex-smokers with = 5 packyears.
  • Drop in FEV1 > 20% after provocation with small particle adenosine < 20 mg at visit 1.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • An asthma exacerbation during the last 6 weeks or upper respiration tract infection during the last 4 weeks prior to inclusion in the study.
  • Severe airway obstruction at baseline, FEV1 < 50% of predicted or < 1.2 liter.
  • Physician diagnosed predominant COPD or any other pulmonary disease that could influence the study results as judged by the investigator.
  • Pregnant or lactating women.
  • Females of childbearing potential without an efficient contraception unless they meet the following definition of post-menopausal: 12 months of natural (spontaneous) amenorrhea or 6 months of spontaneous amenorrhea with serum FSH levels > 40 mIU/mL or the use of one or more of the following acceptable methods of contraception:
  • a) Surgical sterilization (e.g. bilateral tubal ligation, hysterectomy).
  • b) Hormonal contraception (implantable, patch, oral, injectable).
  • c) Barrier methods of contraception: condom or occlusive cap (diaphragm or cervical/vault caps) with spermicidal foam/gel/cream/suppository.
  • d) Continuous abstinence.
  • Periodic abstinence (e.g. calendar, ovulation, symptom-thermal, post-ovulation methods) and withdrawal are not acceptable methods of contraception. Reliable contraception should be maintained throughout the study and for 30 days after study drug discontinuation.

研究者

发起方
niversity Medical Centre Groningen

相似试验

Effects Of extra-fine particle HFA-becLomethasone... | 临床试验